2017
DOI: 10.1056/nejmoa1707572
|View full text |Cite|
|
Sign up to set email alerts
|

Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults

Abstract: The age of transfused red cells did not affect 90-day mortality among critically ill adults. (Funded by the Australian National Health and Medical Research Council and others; TRANSFUSE Australian and New Zealand Clinical Trials Registry number, ACTRN12612000453886 ; ClinicalTrials.gov number, NCT01638416 .).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

9
160
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 150 publications
(170 citation statements)
references
References 16 publications
9
160
0
1
Order By: Relevance
“…Although there are evidences reporting the potential harm of transfusing stored RBCs [1,2,3,4,5,6,7,8,9,10,11], other studies on randomized clinical trials reported no difference in mortality of patients who received fresher versus older RBCs [23,24,25,26]. Most published clinical studies are non-randomized observational studies with methodologic limitations.…”
Section: Discussionmentioning
confidence: 99%
“…Although there are evidences reporting the potential harm of transfusing stored RBCs [1,2,3,4,5,6,7,8,9,10,11], other studies on randomized clinical trials reported no difference in mortality of patients who received fresher versus older RBCs [23,24,25,26]. Most published clinical studies are non-randomized observational studies with methodologic limitations.…”
Section: Discussionmentioning
confidence: 99%
“…19 While large RCTs have not associated PRBC age with mortality, these RCTs did not test PRBCs at the end of shelf life. 79,21 …”
Section: Discussionmentioning
confidence: 99%
“…RECESS4 enrolled adults having scheduled complex cardiac surgery. TRANSFUSE6 and ABLE3 enrolled adults admitted to critical care units. INFORM5 enrolled a broad patient population, but many participants were at low risk of death (the trial’s primary outcome), which may be a limitation when evaluating the clinical consequences of storage duration.…”
Section: Importance Of Case MIXmentioning
confidence: 99%
“…Establishing clinical consequences of storage effects on red blood cells would be of major importance for blood transfusion services. The four most recent randomised trials (ABLE,3 RECESS,4 INFORM,5 and TRANSFUSE6; box 1) analysed nearly 30 000 patients who received transfusions, reporting neither benefit nor harm from cells with different storage durations. These results should provide adequate reassurance that storage duration has no clinical impact.…”
mentioning
confidence: 99%
See 1 more Smart Citation